Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 25, 2019
The FDA has announced a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz used to decrease the amount of acid created by the stomach.
read more
Wednesday, September 25, 2019
Certara® announced the FDA has renewed licenses for Synchrogenix’s electronic Common Technical Document review software, GlobalSubmit REVIEW™ and GlobalSubmit VALIDATE™.
read more
Wednesday, September 25, 2019
Versatope Therapeutics has been awarded a contract with NIAID, a division of the National Institutes of Health (NIH), worth up to $17.9M over five years.
read more
Wednesday, September 25, 2019
LMC Manna Research announced the opening of two new locations in Ottawa and London Ontario.
read more
Thursday, September 26, 2019
Torrent is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets to the consumer level.
read more
Thursday, September 26, 2019
GENEWIZ announced the opening of its European headquarters for its genomics business in Leipzig, Germany.
read more
Friday, September 27, 2019
GlaxoSmithKline (GSK) has completed a $120 million expansion of its manufacturing site in the Philadelphia suburb of Upper Merion, PA.
read more
Friday, September 27, 2019
Translate Bio has entered into a multi-year strategic manufacturing agreement with AMRI in support of the planned expansion of Translate Bio’s cGMP clinical mRNA manufacturing capabilities.
read more
Monday, September 30, 2019
The FDA is announcing an award granting a new five-year contract for the Sentinel System, the FDA’s flagship active surveillance system.
read more
Monday, September 30, 2019
Fate Therapeutics has opened its cGMP compliant manufacturing facility for the clinical production of its off-the-shelf natural killer cell and chimeric antigen receptor (CAR) T-cell product candidates.
read more
Monday, September 30, 2019
Horizon Discovery Group announced the full commercial licensing to Glenmark of its gene-edited Glutamine Synthetase knockout Chinese Hamster Ovary K1 cell line.
read more
Monday, September 30, 2019
Teneobio announced one of the Janssen Companies has elected to exercise a commercial option to license and advance an undisclosed multispecific product for development in an oncology indication.
read more
Monday, September 30, 2019
MMS Holdings has collaborated with Oracle Health Sciences and a specialized Oncology pharmaceutical company.
read more
Monday, September 30, 2019
ASLAN and Bukwang announced they have established a new joint venture to develop preclinical aryl hydrocarbon receptor (AhR) antagonists from ASLAN’s early stage pipeline.
read more
Tuesday, October 01, 2019
N-SIDE announced AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials.
read more